
GW 627368X
CAS No. 439288-66-1
GW 627368X( GW627368X | GW 627368X | GW-627368X | GW627368 )
Catalog No. M14493 CAS No. 439288-66-1
GW627368(GW627368X) is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor(Ki= 100 nM) with additional human TP receptor affinity(Ki= 150 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 30 | In Stock |
![]() ![]() |
5MG | 47 | In Stock |
![]() ![]() |
10MG | 71 | In Stock |
![]() ![]() |
25MG | 120 | In Stock |
![]() ![]() |
50MG | 203 | In Stock |
![]() ![]() |
100MG | 357 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameGW 627368X
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW627368(GW627368X) is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor(Ki= 100 nM) with additional human TP receptor affinity(Ki= 150 nM).
-
DescriptionGW627368(GW627368X) is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor(Ki= 100 nM) with additional human TP receptor affinity(Ki= 150 nM).
-
In Vitro——
-
In VivoAnimal Model:6-8 weeks Swiss albino mice Dosage:0 mg/kg, 5 mg/kg, 10 mg/kg, 15 mg/kg, 15 mg/kg Administration:Oral administration, every alternate day for 28 days Result:Displayed anti-tumor and anti-proliferative potential in sarcoma 180 bearing mice.
-
SynonymsGW627368X | GW 627368X | GW-627368X | GW627368
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorEP4
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number439288-66-1
-
Formula Weight544.62
-
Molecular FormulaC30H28N2O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mg/mL
-
SMILESO=C(NS(=O)(C1=CC=CC=C1)=O)CC2=CC=C(N(CC3=C4C(OCC)=C(C=CC=C5)C5=C3OCC)C4=O)C=C2
-
Chemical Name2-(4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl)-N-(phenylsulfonyl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wilson RJ, et al. Br J Pharmacol. 2006 Jun; 148(3): 326-39.
molnova catalog



related products
-
Vidupiprant
Vidupiprant is an effective dual antagonist of CRTH2 and prostanoid D receptor with IC50s of 8 nM and 35 nM in human plasma.
-
OBE022
OBE022 is a potent, highly selective, orally active antagonist of the contractile PGF2α prostaglandin receptor with Kb of 5.9 nM.
-
TG6-129
TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.